Clinical trial
Irinotecan in Treating Patients With Advanced Gallbladder or Bile Duct Cancer
NCT00003276 · Alliance for Clinical Trials in Oncology, Other · Completed
Key facts
| NCT number | NCT00003276 |
|---|---|
| Title | Irinotecan in Treating Patients With Advanced Gallbladder or Bile Duct Cancer |
| Official title | A Phase II Study of CPT-11 in Patients With Advanced Gallbladder or Bile Duct Tumors |
| Lead sponsor | Alliance for Clinical Trials in Oncology, Other |
| Collaborators | National Cancer Institute (NCI) NIH |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Gallbladder Cancer |
| Intervention type | Drug |
| Interventions | irinotecan hydrochloride |
| Enrollment | 40 |
| Start date | Mar 1, 1998 |
| Primary completion | Mar 1, 2001 |
| Completion | Mar 1, 2001 |
| First posted | Apr 30, 2004 |
| Last update posted | Jul 6, 2016 |
| Countries | Canada, United States |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: